002940 昂利康
午间休市 05-13 11:30:00
资讯
新帖
简况
异动快报：昂利康（002940）5月13日10点47分触及涨停板
证券之星 · 10:55
异动快报：昂利康（002940）5月13日10点47分触及涨停板
昂利康：5月11日接受机构调研，丁建圣,张志康参与
证券之星 · 05-12 10:32
昂利康：5月11日接受机构调研，丁建圣,张志康参与
5月11日昂利康涨7.10%，国泰海通新锐量化选股混合A基金重仓该股
证券之星 · 05-11 16:36
5月11日昂利康涨7.10%，国泰海通新锐量化选股混合A基金重仓该股
昂利康（002940）披露将参加浙江辖区上市公司2026年投资者网上集体接待日暨2025年度业绩说明会，5月6日股价上涨0.21%
证券之星 · 05-06
昂利康（002940）披露将参加浙江辖区上市公司2026年投资者网上集体接待日暨2025年度业绩说明会，5月6日股价上涨0.21%
每周股票复盘：昂利康（002940）Q1净利增10.99%
证券之星 · 05-03
每周股票复盘：昂利康（002940）Q1净利增10.99%
昂利康（002940）披露2025年度利润分配预案，4月29日股价下跌3.34%
证券之星 · 04-29
昂利康（002940）披露2025年度利润分配预案，4月29日股价下跌3.34%
图解昂利康年报：第四季度单季净利润同比增长57.07%
证券之星 · 04-29
图解昂利康年报：第四季度单季净利润同比增长57.07%
昂利康最新公告：获得富马酸伏诺拉生片药品注册证书
证券之星 · 04-20
昂利康最新公告：获得富马酸伏诺拉生片药品注册证书
4月20日昂利康（002940）龙虎榜数据：机构净买入4806.93万元，北向资金净买入6135.23万元
证券之星 · 04-20
4月20日昂利康（002940）龙虎榜数据：机构净买入4806.93万元，北向资金净买入6135.23万元
昂利康（002940）披露股票交易异常波动公告，4月20日股价上涨1.63%
证券之星 · 04-20
昂利康（002940）披露股票交易异常波动公告，4月20日股价上涨1.63%
4月17日昂利康（002940）龙虎榜数据：机构净买入5526.18万元（3日），北向资金净买入6736.33万元（3日）
证券之星 · 04-17
4月17日昂利康（002940）龙虎榜数据：机构净买入5526.18万元（3日），北向资金净买入6736.33万元（3日）
4月17日昂利康（002940）涨停分析：过评提速、创新药临床驱动
证券之星 · 04-17
4月17日昂利康（002940）涨停分析：过评提速、创新药临床驱动
4月1日昂利康（002940）涨停分析：创新药突破、集采放量驱动
证券之星 · 04-16
4月1日昂利康（002940）涨停分析：创新药突破、集采放量驱动
昂利康最新公告：克立硼罗软膏获药品注册证书
证券之星 · 04-15
昂利康最新公告：克立硼罗软膏获药品注册证书
昂利康（002940）披露2026年第一次临时股东会决议公告，4月7日股价上涨0.63%
证券之星 · 04-07
昂利康（002940）披露2026年第一次临时股东会决议公告，4月7日股价上涨0.63%
昂利康：目前公司与药石科技暂无合作事项
证券之星 · 04-02
昂利康：目前公司与药石科技暂无合作事项
3月27日昂利康涨7.01%，华泰柏瑞恒泽混合A基金重仓该股
证券之星 · 03-27
3月27日昂利康涨7.01%，华泰柏瑞恒泽混合A基金重仓该股
3月23日昂利康跌5.62%，华泰柏瑞恒泽混合A基金重仓该股
证券之星 · 03-23
3月23日昂利康跌5.62%，华泰柏瑞恒泽混合A基金重仓该股
3月20日昂利康创60日新低，华泰柏瑞恒泽混合A基金重仓该股
证券之星 · 03-20
3月20日昂利康创60日新低，华泰柏瑞恒泽混合A基金重仓该股
昂利康（002940）披露调整2025年度向特定对象发行A股股票方案公告，3月19日股价下跌2.29%
证券之星 · 03-19
昂利康（002940）披露调整2025年度向特定对象发行A股股票方案公告，3月19日股价下跌2.29%
加载更多
公司概况
公司名称：
浙江昂利康制药股份有限公司
所属行业：
医药制造业
上市日期：
2018-10-23
主营业务：
浙江昂利康制药股份有限公司的主营业务是化学原料药、化学制剂及特色中间体系列产品的研发、生产和销售。公司的主要产品是抗感染类、心血管类、泌尿系统类（肾病类）、麻醉疼痛类、抗雄性激素类。
发行价格：
23.07
{"stockData":{"symbol":"002940","market":"SZ","secType":"STK","nameCN":"昂利康","latestPrice":36.43,"timestamp":1778647764000,"preClose":33.12,"halted":0,"volume":24595570,"delay":0,"changeRate":0.0999,"floatShares":185000000,"shares":202000000,"eps":0.6306,"marketStatus":"午间休市","change":3.31,"latestTime":"05-13 11:30:00","open":33.82,"high":36.43,"low":33.31,"amount":860000000,"amplitude":0.0942,"askPrice":0,"askSize":0,"bidPrice":36.43,"bidSize":53543,"shortable":0,"etf":0,"ttmEps":0.6306,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778648400000},"marketStatusCode":3,"adr":0,"adjPreClose":33.12,"symbolType":"stock","openAndCloseTimeList":[[1778635800000,1778643000000],[1778648400000,1778655600000]],"highLimit":36.43,"lowLimit":29.81,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":201728186,"isCdr":false,"pbRate":4.06,"roa":"--","peRate":57.770377,"roe":"1.08%","epsLYR":0.62,"committee":0,"marketValue":7349000000,"turnoverRate":0.1328,"status":0,"floatMarketCap":6750000000},"requestUrl":"/m/hq/s/002940","defaultTab":"news","newsList":[{"id":"2635278261","title":"异动快报：昂利康（002940）5月13日10点47分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2635278261","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635278261?lang=zh_cn&edition=full","pubTime":"2026-05-13 10:55","pubTimestamp":1778640924,"startTime":"0","endTime":"0","summary":"证券之星5月13日盘中消息，10点47分昂利康（002940）触及涨停板。其所属行业化学制药目前下跌。领涨股为翰宇药业。该股为合成生物，宠物经济，化学原料药概念热股，当日合成生物概念上涨0.23%，宠物经济概念上涨0.17%。5月12日的资金流向数据方面，主力资金净流出2278.2万元，占总成交额3.4%，游资资金净流出527.86万元，占总成交额0.79%，散户资金净流入2806.05万元，占总成交额4.19%。近5日资金流向一览见下表：昂利康主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300015237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634250872","title":"昂利康：5月11日接受机构调研，丁建圣,张志康参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2634250872","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634250872?lang=zh_cn&edition=full","pubTime":"2026-05-12 10:32","pubTimestamp":1778553123,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年5月12日昂利康发布公告称公司于2026年5月11日接受机构调研，丁建圣,张志康参与。费森尤斯卡比持有子公司昂利泰的部分股权。昂利康2026年一季报显示，一季度公司主营收入3.4亿元，同比下降1.55%；归母净利润1765.48万元，同比上升10.99%；扣非净利润1604.23万元，同比上升82.96%；负债率39.27%，投资收益-357.62万元，财务费用208.31万元，毛利率36.62%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200012770.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634409131","title":"5月11日昂利康涨7.10%，国泰海通新锐量化选股混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634409131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634409131?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:36","pubTimestamp":1778488589,"startTime":"0","endTime":"0","summary":"证券之星消息，5月11日昂利康涨7.10%，收盘报34.25元，换手率16.78%，成交量31.09万手，成交额10.51亿元。重仓昂利康的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为国泰海通资管的国泰海通新锐量化选股混合A。国泰海通新锐量化选股混合A目前规模为0.2亿元，最新净值1.5082，较上一交易日上涨0.71%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100022146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1564","BK0183","BK0028","601211","BK0188","BK0012","BK1147","002940","02611","BK0239","BK0201","BK0276","BK0184"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633131773","title":"昂利康（002940）披露将参加浙江辖区上市公司2026年投资者网上集体接待日暨2025年度业绩说明会，5月6日股价上涨0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633131773","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633131773?lang=zh_cn&edition=full","pubTime":"2026-05-06 22:26","pubTimestamp":1778077580,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，昂利康报收于33.15元，较前一交易日上涨0.21%，最新总市值为66.87亿元。该股当日开盘33.19元，最高33.58元，最低32.66元，成交额达4亿元，换手率为6.5%。近日，昂利康发布《关于参加浙江辖区上市公司2026年投资者网上集体接待日暨2025年度业绩说明会的公告》。投资者可于2026年5月12日15:00前通过指定链接或二维码提交问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600039868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632903674","title":"每周股票复盘：昂利康（002940）Q1净利增10.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632903674","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632903674?lang=zh_cn&edition=full","pubTime":"2026-05-03 03:10","pubTimestamp":1777749020,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，昂利康报收于33.08元，较上周的39.9元下跌17.09%。本周，昂利康4月27日盘中最高价报42.98元。交易信息汇总昂利康因日振幅值达到15%的前5只证券，于2026年4月27日登上龙虎榜。股本股东变化截至2026年3月31日，昂利康股东户数为4.02万户，较2025年12月31日增加729户，增幅1.85%。业绩披露要点昂利康2026年一季报显示，主营收入3.4亿元，同比下降1.55%；归母净利润1765.48万元，同比上升10.99%；扣非净利润1604.23万元，同比上升82.96%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300000601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631859487","title":"昂利康（002940）披露2025年度利润分配预案，4月29日股价下跌3.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631859487","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631859487?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:16","pubTimestamp":1777457773,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘，昂利康报收于34.17元，较前一交易日下跌3.34%，最新总市值为68.93亿元。公司于2026年4月29日披露《关于2025年度利润分配预案的公告》。公告显示，浙江昂利康制药股份有限公司于2026年4月27日召开第四届董事会第十八次会议，审议通过《2025年度利润分配预案》。公司2025年度合并报表归属于母公司股东的净利润为125,441,397.57元，母公司累计可供分配利润为695,766,639.16元。2025年现金分红及股份回购总额占归母净利润约39.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900057954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631580896","title":"图解昂利康年报：第四季度单季净利润同比增长57.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631580896","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631580896?lang=zh_cn&edition=full","pubTime":"2026-04-29 02:42","pubTimestamp":1777401772,"startTime":"0","endTime":"0","summary":"证券之星消息，昂利康2025年年报显示，当年度公司主营收入14.25亿元，同比下降7.35%；归母净利润1.25亿元，同比上升56.15%；扣非净利润8655.71万元，同比上升78.82%；其中2025年第四季度，公司单季度主营收入3.7亿元，同比下降11.21%；单季度归母净利润4775.15万元，同比上升57.07%；单季度扣非净利润3079.19万元，同比上升262.73%；负债率36.72%，投资收益-1792.89万元，财务费用-32.93万元，毛利率39.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900007168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628072962","title":"昂利康最新公告：获得富马酸伏诺拉生片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2628072962","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628072962?lang=zh_cn&edition=full","pubTime":"2026-04-20 21:59","pubTimestamp":1776693581,"startTime":"0","endTime":"0","summary":"昂利康(002940.SZ)公告称，公司近日收到国家药监局签发的富马酸伏诺拉生片《药品注册证书》。该药品主要用于治疗反流性食管炎及根除幽门螺杆菌。根据国家相关政策规定，本次获得证书视同通过一致性评价。此次获证将进一步丰富公司的仿制药产品管线，增强综合竞争力。截至2026年4月19日，该品种共有48家企业视同通过一致性评价，市场竞争较为激烈。鉴于医药行业特殊性，药品销售受政策及市场环境等因素影响，具体销售情况存在不确定性，敬请投资者注意投资风险。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000036291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628450757","title":"4月20日昂利康（002940）龙虎榜数据：机构净买入4806.93万元，北向资金净买入6135.23万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2628450757","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628450757?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:16","pubTimestamp":1776676572,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年4月20日公布的交易公开信息显示，昂利康因日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2026年4月20日收盘，昂利康报收于39.8元，上涨1.63%，换手率32.69%，成交量60.57万手，成交额24.83亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入4806.93万元，北向资金合计净买入6135.23万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000023657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628745412","title":"昂利康（002940）披露股票交易异常波动公告，4月20日股价上涨1.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628745412","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628745412?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:13","pubTimestamp":1776676393,"startTime":"0","endTime":"0","summary":"截至2026年4月20日收盘，昂利康报收于39.8元，较前一交易日上涨1.63%，最新总市值为80.29亿元。该股当日开盘42.1元，最高43.08元，最低38.32元，成交额达24.83亿元，换手率为32.69%。公司于近日披露《股票交易异常波动公告》。公告显示，昂利康股票连续3个交易日收盘价格涨幅偏离值累计超过20%，构成股票交易异常波动。董事会确认无应披露而未披露事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000023321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628274677","title":"4月17日昂利康（002940）龙虎榜数据：机构净买入5526.18万元（3日），北向资金净买入6736.33万元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2628274677","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628274677?lang=zh_cn&edition=full","pubTime":"2026-04-17 17:16","pubTimestamp":1776417370,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年4月17日公布的交易公开信息显示，昂利康因连续三个交易日内，涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年4月17日收盘，昂利康报收于39.16元，上涨10.0%，已连续涨停2天，换手率21.42%，成交量39.68万手，成交额15.04亿元。从龙虎榜公布的三日买卖数据来看，机构合计净买入5526.18万元，北向资金合计净买入6736.33万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700032641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628276898","title":"4月17日昂利康（002940）涨停分析：过评提速、创新药临床驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2628276898","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628276898?lang=zh_cn&edition=full","pubTime":"2026-04-17 15:44","pubTimestamp":1776411875,"startTime":"0","endTime":"0","summary":"证券之星消息，昂利康4月17日涨停收盘，收盘价39.16元。该股于10点17分涨停，1次打开涨停，截止收盘封单资金为6392.48万元，占其流通市值0.88%。今日昂利康涨停的可能因素有：公司于2026年4月15日公告盐酸阿罗洛尔片通过一致性评价，为国内第二家获批企业；同期披露子公司创新药AL-001获CDE默示许可进入I期临床；叠加近期医药板块政策面回暖，创新药与仿制药双轮驱动逻辑受市场关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700025764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","159992","BK0239","002940","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627267717","title":"4月1日昂利康（002940）涨停分析：创新药突破、集采放量驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2627267717","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627267717?lang=zh_cn&edition=full","pubTime":"2026-04-16 15:42","pubTimestamp":1776325362,"startTime":"0","endTime":"0","summary":"证券之星消息，昂利康4月16日涨停收盘，收盘价35.6元。今日昂利康涨停的可能因素有：定增方案修订拟募资11.2亿元加码创新药研发，重点推进ALK-N001 I期临床；年内获头孢克肟等6个药品证书及3个视同过评批件；12个产品拟中选国家集采；子公司获批“吸入用七氟烷（宠物用）”兽药批件，正式切入千亿级宠物药赛道；2025年净利预增36.93%-71.78%，年报预增兑现；叠加创新药+原料药+集采+宠物药多重概念共振。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600023603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159992","002940","BK1161","BK1574","06978","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627003754","title":"昂利康最新公告：克立硼罗软膏获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2627003754","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627003754?lang=zh_cn&edition=full","pubTime":"2026-04-15 17:22","pubTimestamp":1776244965,"startTime":"0","endTime":"0","summary":"昂利康(002940.SZ)公告称，公司近日收到国家药监局签发的克立硼罗软膏《药品注册证书》。该药品适用于3月龄及以上轻度至中度特应性皮炎患者的局部外用治疗，规格为2%(30g：0.6g)。根据国家相关政策规定，本次获得《药品注册证书》视同通过一致性评价。此次获批将进一步丰富公司的仿制药产品管线，增强综合竞争力。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500031378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625323959","title":"昂利康（002940）披露2026年第一次临时股东会决议公告，4月7日股价上涨0.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625323959","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625323959?lang=zh_cn&edition=full","pubTime":"2026-04-07 22:12","pubTimestamp":1775571141,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，昂利康报收于33.76元，较前一交易日上涨0.63%，最新总市值为68.1亿元。该股当日开盘33.01元，最高34.76元，最低31.61元，成交额达8.79亿元，换手率为14.24%。近日，浙江昂利康制药股份有限公司发布《2026年第一次临时股东会决议公告》。公告显示，公司于2026年4月7日召开2026年第一次临时股东会，审议通过了关于调整公司2025年度向特定对象发行A股股票方案及相关修订文件的议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700033378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624241735","title":"昂利康：目前公司与药石科技暂无合作事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2624241735","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624241735?lang=zh_cn&edition=full","pubTime":"2026-04-02 11:34","pubTimestamp":1775100889,"startTime":"0","endTime":"0","summary":"证券之星消息，昂利康(002940)04月01日在投资者关系平台上答复投资者关心的问题。投资者提问：1. 药石科技在分子砌块、连续流工艺、ADC/TPD关键中间体等领域具备国内独一档的技术壁垒，也是很多创新药公司早期研发和CMC开发的重要合作伙伴。请问贵司在管线研发中，是否与药石科技有合作？未来是否有计划在早期化合物发现、工艺开发或商业化生产层面开展合作？昂利康回复：您好，目前公司与药石科技暂无合作事项，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200015083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0239","002940","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622849338","title":"3月27日昂利康涨7.01%，华泰柏瑞恒泽混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622849338","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622849338?lang=zh_cn&edition=full","pubTime":"2026-03-27 16:16","pubTimestamp":1774599388,"startTime":"0","endTime":"0","summary":"证券之星消息，3月27日昂利康涨7.01%，收盘报31.16元，换手率8.91%，成交量16.5万手，成交额5.1亿元。重仓昂利康的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为华泰柏瑞基金的华泰柏瑞恒泽混合A。华泰柏瑞恒泽混合A目前规模为0.41亿元，最新净值1.116，较上一交易日上涨0.01%，近一年上涨3.17%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700033448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621779858","title":"3月23日昂利康跌5.62%，华泰柏瑞恒泽混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621779858","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621779858?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:56","pubTimestamp":1774256176,"startTime":"0","endTime":"0","summary":"证券之星消息，3月23日昂利康跌5.62%创60日新低，收盘报27.38元，换手率2.72%，成交量5.03万手，成交额1.41亿元。重仓昂利康的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为华泰柏瑞基金的华泰柏瑞恒泽混合A。华泰柏瑞恒泽混合A目前规模为0.41亿元，最新净值1.1176，较上一交易日下跌0.04%，近一年上涨3.1%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620861347","title":"3月20日昂利康创60日新低，华泰柏瑞恒泽混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620861347","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620861347?lang=zh_cn&edition=full","pubTime":"2026-03-20 16:24","pubTimestamp":1773995044,"startTime":"0","endTime":"0","summary":"证券之星消息，3月20日昂利康创60日新低，收盘报29.01元，当日跌2.68%，换手率1.63%，成交量3.03万手，成交额8926.51万元。重仓昂利康的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为华泰柏瑞基金的华泰柏瑞恒泽混合A。华泰柏瑞恒泽混合A目前规模为0.41亿元，最新净值1.118，较上一交易日下跌0.09%，近一年上涨3.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000027709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620221822","title":"昂利康（002940）披露调整2025年度向特定对象发行A股股票方案公告，3月19日股价下跌2.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620221822","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620221822?lang=zh_cn&edition=full","pubTime":"2026-03-19 22:31","pubTimestamp":1773930671,"startTime":"0","endTime":"0","summary":"截至2026年3月19日收盘，昂利康报收于29.81元，较前一交易日下跌2.29%，最新总市值为60.14亿元。该股当日开盘30.2元，最高30.43元，最低29.65元，成交额达9091.43万元，换手率为1.64%。公告显示，公司于2026年3月18日召开第四届董事会第十七次会议，审议通过了关于调整公司2025年度向特定对象发行A股股票方案的议案。因ALK-N001项目临床进展及ALK-N002项目交易对方内部审批进度原因，董事会同意将募集资金总额由116,000.00万元调整为112,000.00万元，全部用于创新药研发项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900039846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","159982","BK0239","399300"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778647813917,"stockEarnings":[{"period":"1week","weight":0.0012},{"period":"1month","weight":0.067},{"period":"3month","weight":0.016},{"period":"6month","weight":-0.2545},{"period":"1year","weight":1.4612},{"period":"ytd","weight":-0.0119}],"compareEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":0.0573},{"period":"3month","weight":0.02},{"period":"6month","weight":0.0459},{"period":"1year","weight":0.2509},{"period":"ytd","weight":0.0619}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江昂利康制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"40232人(较上一季度增加1.85%)","perCapita":"4605股","listingDate":"2018-10-23","address":"浙江省绍兴市嵊州市嵊州大道北1000号","registeredCapital":"20172万元","survey":" 浙江昂利康制药股份有限公司的主营业务是化学原料药、化学制剂及特色中间体系列产品的研发、生产和销售。公司的主要产品是抗感染类、心血管类、泌尿系统类（肾病类）、麻醉疼痛类、抗雄性激素类。","listedPrice":23.07},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昂利康(002940)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昂利康(002940)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昂利康,002940,昂利康股票,昂利康股票老虎,昂利康股票老虎国际,昂利康行情,昂利康股票行情,昂利康股价,昂利康股市,昂利康股票价格,昂利康股票交易,昂利康股票购买,昂利康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昂利康(002940)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昂利康(002940)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}